NANJING, China, 31. Mai 2023 /PRNewswire/ — Vazyme (688105.SH), Chinas führendes Biotechnologieunternehmen, hat offiziell eine Vereinbarung über eine globale strategische Zusammenarbeit mit Azenta Life Sciences („Azenta”, Nasdaq: AZTA) unterzeichnet, die die Etablierung eines…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.